The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery

Clin Microbiol Infect. 2021 Oct;27(10):1481-1487. doi: 10.1016/j.cmi.2021.02.002. Epub 2021 Feb 12.

Abstract

Objectives: Compared to cephalosporin-based prophylaxis, ertapenem prophylaxis lowers the risk of surgical site infection among carriers of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PEs) undergoing colorectal surgery. We aimed to determine whether ertapenem prophylaxis leads to increased postoperative colonization with carbapenem-resistant Enterobacterales (CREs) and third-generation-cephalosporin-resistant Enterobacterales (3GCR-Es).

Methods: This study was nested within a quality improvement study of prophylaxis for ESBL-PE carriers undergoing colorectal surgery. Patients were screened 4-6 days after surgery for carriage of ESBL-PEs or other 3GCR-Es and CREs. When CREs were detected, pre- and postsurgical clones were compared using Fourier-transform infrared (FT-IR) spectroscopy.

Results: The sample consisted of 56 patients who carried ESBL-PEs before surgery and received cefuroxime/metronidazole prophylaxis (Group 1), 66 who carried ESBL-PEs before surgery and received ertapenem (Group 2), and 103 ESBL-PE non-carriers who received cefuroxime/metronidazole prophylaxis (Group 3). CRE carriage was detected postoperatively in one patient (1.5%) in Group 2 versus eight patients (14.3%) in Group 1 (RD -12.8%; 95%CI -22.4% to -3.1%). For seven out of nine patients, preoperative ESBL-PE and postoperative CRE isolates were compared; in five of them, the pre- and postoperative clones were identical. Postoperative 3GCR-E carriage was detected in 37 patients (56.1%) in Group 2 versus 46 patients in Group 1 (82.1%) (aRD -20.7%, 95%CI -37.3% to -4.1%).

Conclusions: Among ESBL-PE carriers undergoing colorectal surgery, detection of short-term postsurgical colonization by CREs and 3GCR-Es was significantly lower among patients who received ertapenem prophylaxis than those who received cephalosporin-metronidazole prophylaxis. Resistance development in a colonizing bacterial clone, rather than carbapenemase acquisition, was the major mechanism of carbapenem resistance.

Keywords: Antibiotic prophylaxis; Carbapenem-resistant Enterobacterales; Colorectal surgery; Ertapenem; Extended-spectrum β-lactamase.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Carbapenems
  • Cefuroxime / therapeutic use*
  • Cephalosporins / therapeutic use
  • Colorectal Surgery
  • Digestive System Surgical Procedures*
  • Drug Resistance, Bacterial
  • Enterobacteriaceae Infections* / drug therapy
  • Enterobacteriaceae Infections* / epidemiology
  • Enterobacteriaceae Infections* / prevention & control
  • Ertapenem / therapeutic use*
  • Humans
  • Metronidazole / therapeutic use*
  • Spectroscopy, Fourier Transform Infrared
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Cephalosporins
  • Metronidazole
  • beta-Lactamases
  • Ertapenem
  • Cefuroxime